Atlas Trials

Ketohexokinase Inhibition in NAFLD

Clinical trial NCT05463575 · COMPLETED

Trial details

NCT number
NCT05463575
Sponsor
Maastricht University Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
NAFLD
Start date
2022-10-01
Primary completion
2023-11-24
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.